Stay updated with breaking news from 91307c10. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
United Therapeutics Co. (NASDAQ:UTHR – Get Free Report)’s stock price traded down 3.4% during mid-day trading on Wednesday following insider selling activity. The company traded as low as $236.07 and last traded at $239.32. 136,394 shares were traded during trading, a decline of 66% from the average session volume of 400,432 shares. The stock had […]
TFB Advisors LLC decreased its stake in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 45.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,013 shares of the biotechnology company’s stock after selling 852 shares during the […]
StockNews.com downgraded shares of United Therapeutics (NASDAQ:UTHR – Free Report) from a strong-buy rating to a buy rating in a report published on Tuesday morning. Other equities analysts have also issued research reports about the company. SVB Leerink started coverage on United Therapeutics in a research note on Monday, February 5th. They set an outperform […]
Shares of United Therapeutics Co. (NASDAQ:UTHR – Get Free Report) gapped up prior to trading on Monday . The stock had previously closed at $237.90, but opened at $247.86. United Therapeutics shares last traded at $241.56, with a volume of 125,914 shares. Analyst Ratings Changes Several research firms have recently weighed in on UTHR. HC […]
Jacobs Levy Equity Management Inc. lessened its stake in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) by 14.2% in the third quarter, HoldingsChannel.com reports. The institutional investor owned 192,676 shares of the biotechnology company’s stock after selling 31,881 shares during the quarter. Jacobs Levy Equity Management Inc.’s holdings in United Therapeutics were worth […]